Mustang Stock Performance

MBIO
 Stock
  

USD 0.59  0.02  3.28%   

The company secures a Beta (Market Risk) of 1.7026, which conveys a somewhat significant risk relative to the market. Let's try to break down what Mustang's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mustang Bio will likely underperform. Even though it is essential to pay attention to Mustang Bio price patterns, it is always good to be careful when utilizing equity historical price patterns. Our philosophy towards estimating any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Mustang Bio exposes twenty-seven different technical indicators, which can help you to evaluate its performance. Mustang Bio has an expected return of -0.81%. Please be advised to verify Mustang Bio potential upside, as well as the relationship between the kurtosis and day typical price to decide if Mustang Bio performance from the past will be repeated at some point in the near future.
  
Refresh
Mustang Performance
0 of 100
Over the last 90 days Mustang Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in July 2022. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more

Mustang Price Channel

Quick Ratio10.14
Fifty Two Week Low0.5600
Target High Price11.00
Fifty Two Week High3.6150
Target Low Price6.00

Mustang Bio Relative Risk vs. Return Landscape

If you would invest  104.00  in Mustang Bio on April 1, 2022 and sell it today you would lose (47.00)  from holding Mustang Bio or give up 45.19% of portfolio value over 90 days. Mustang Bio is currently does not generate positive expected returns and assumes 5.6847% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Mustang, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Mustang Bio is expected to under-perform the market. In addition to that, the company is 3.9 times more volatile than its market benchmark. It trades about -0.14 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.14 per unit of volatility.

Mustang Bio Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Mustang Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mustang Bio, and traders can use it to determine the average amount a Mustang Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.142

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsMBIO
Estimated Market Risk
 5.68
  actual daily
 
 49 %
of total potential
 
4949
Expected Return
 -0.81
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.14
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Mustang Bio is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mustang Bio by adding it to a well-diversified portfolio.

About Mustang Bio Performance

To evaluate Mustang Bio Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Mustang Bio generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Mustang Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Mustang Bio stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Mustang's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Average Assets(0.49) (0.52) 
Return on Average Equity(0.53) (0.57) 
Return on Invested Capital(10.47) (10.75) 
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. Mustang Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

Things to note about Mustang Bio

Checking the ongoing alerts about Mustang Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mustang Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Mustang Bio Alerts

Equity Alerts and Improvement Suggestions

Mustang Bio generated a negative expected return over the last 90 days
Mustang Bio has high historical volatility and very poor performance
Mustang Bio has some characteristics of a very speculative penny stock
Net Loss for the year was (66.37 M).
Mustang Bio currently holds about 109.62 M in cash with (53.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Mustang Bio has a frail financial position based on the latest SEC disclosures
Roughly 21.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.marketwatch.com: Mustang Bio Shares Rise 20 percent After Orphan Drug Status for MB-106 Lymphoma Treatment - MarketWatch
Additionally, see Stocks Correlation. Note that the Mustang Bio information on this page should be used as a complementary analysis to other Mustang Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Mustang Stock analysis

When running Mustang Bio price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
61.1 M
Return On Assets
-0.32
Return On Equity
-0.62
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Mustang Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.